Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management.

cardiology epigenetics gene therapy genetics hypertrophic cardiomyopathy pathophysiology signal transduction

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 26 07 2021
accepted: 28 08 2021
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 15 10 2021
Statut: epublish

Résumé

Hypertrophic cardiomyopathy (HCM) is a genetically acquired disease of cardiac myocytes. Studies show that 70% of this disease is a result of different mutations in various sarcomere genes. This review aims to discuss several genetic mutations, epigenetic factors, and signal transduction pathways leading to the development of HCM. In addition, this article elaborates on recent advances in gene therapies and their implications for managing this condition. We start by discussing the founding mutations in HCM and their effect on power stroke generation. The less explored field of epigenetics including methylation, acetylation, and the role of different micro RNAs in the development of cardiac muscle hypertrophy has been highlighted in this article. The signal transduction pathways that lead to gene transcription, which in turn lead to increased protein synthesis of cardiac muscle fibers are elaborated. Finally, the microscopic events leading to the pathophysiologic macro events of cardiac failure, and the current experimental trials of gene therapy models, and the clustered regularly interspaced short palindromic repeats (CRISPR) type 2 system proteins, are discussed. We have concluded our discussion by emphasizing the need for more studies on epigenomics and experimental designs for gene therapy in HCM patients. This review focuses on the process of HCM from initial mutation to the development of phenotypic expression and various points of intervention in cardiac myocardial hypertrophy development.

Identifiants

pubmed: 34646605
doi: 10.7759/cureus.17548
pmc: PMC8481153
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e17548

Informations de copyright

Copyright © 2021, Pradeep et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Pflugers Arch. 2014 Feb;466(2):215-23
pubmed: 24337823
BMJ. 2015 Feb 19;350:g7611
pubmed: 25697663
Eur Heart J. 2005 Nov;26(22):2457-62
pubmed: 16087648
Biomed Res Int. 2015;2015:983290
pubmed: 26504850
Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S388-S415
pubmed: 31737545
Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H566-72
pubmed: 19122165
J Mol Cell Cardiol. 2015 Feb;79:234-43
pubmed: 25463273
Pflugers Arch. 2019 May;471(5):807-815
pubmed: 29971600
Circulation. 2010 Dec 7;122(23):2430-40; discussion 2440
pubmed: 21135371
Eur J Hum Genet. 2002 Nov;10(11):741-8
pubmed: 12404107
J Med Genet. 2000 Sep;37(9):E18
pubmed: 10978365
Int J Cardiol. 2015 Oct 1;196:115-22
pubmed: 26086795
Circ Res. 2017 Sep 15;121(7):749-770
pubmed: 28912181
Am J Med Genet A. 2019 Mar;179(3):365-372
pubmed: 30588760
J Clin Invest. 1992 Nov;90(5):1666-71
pubmed: 1430197
Neth Heart J. 2011 Aug;19(7-8):344-51
pubmed: 21533915
J Am Coll Cardiol. 2000 Jan;35(1):36-44
pubmed: 10636256
Environ Mol Mutagen. 2011 Mar;52(2):161-4
pubmed: 20740642
Cardiovasc Res. 2004 Aug 15;63(3):450-7
pubmed: 15276470
J Cell Mol Med. 2012 Apr;16(4):911-9
pubmed: 21696541
N Engl J Med. 1992 Apr 23;326(17):1108-14
pubmed: 1552912
J Muscle Res Cell Motil. 2012 May;33(1):75-80
pubmed: 22057632
Pharmacol Res. 2010 Apr;61(4):269-80
pubmed: 19969085
Hum Genet. 1996 Apr;97(4):457-61
pubmed: 8834242
Oncol Rep. 2017 Dec;38(6):3465-3472
pubmed: 29039602
Nature. 2017 Aug 24;548(7668):413-419
pubmed: 28783728
Lancet. 2016 Mar 19;387(10024):1178-86
pubmed: 26803443
Genome Res. 2014 Jun;24(6):1012-9
pubmed: 24696461
J Mark Access Health Policy. 2017 Jan 3;5(1):1265293
pubmed: 28265348
Medicina (Kaunas). 2019 Jun 23;55(6):
pubmed: 31234582
Mol Cell Biol. 2004 Oct;24(19):8374-85
pubmed: 15367659
Eur Heart J. 2017 Dec 7;38(46):3461-3468
pubmed: 28082330
J Cardiol. 2019 May;73(5):438-444
pubmed: 30600190
Cancer Res. 1998 May 15;58(10):2070-5
pubmed: 9605744
J Am Coll Cardiol. 2003 Mar 19;41(6):981-6
pubmed: 12651045
Cell. 2002 Aug 23;110(4):479-88
pubmed: 12202037
J Clin Invest. 1997 Jul 15;100(2):475-82
pubmed: 9218526
Hypertension. 2002 Jan;39(1):87-92
pubmed: 11799084
Mol Ther. 2014 Dec;22(12):2038-2045
pubmed: 25023328
Biomed Res Int. 2017;2017:1278436
pubmed: 29094041
J Clin Invest. 2003 Sep;112(6):863-71
pubmed: 12975471
PLoS One. 2012;7(9):e44744
pubmed: 23024758
J Am Coll Cardiol. 2007 Mar 27;49(12):1251-64
pubmed: 17394955
Mutat Res. 2011 Dec 1;717(1-2):85-90
pubmed: 21402084
Nat Clin Pract Cardiovasc Med. 2007 May;4(5):232-3
pubmed: 17457348
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9905-9
pubmed: 1384064
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
J Am Coll Cardiol. 1999 May;33(6):1590-5
pubmed: 10334429
Cell. 2016 Jun 2;165(6):1319-1322
pubmed: 27259145
Circulation. 2011 Jul 19;124(3):304-13
pubmed: 21709064
N Engl J Med. 2010 Aug 5;363(6):552-63
pubmed: 20818890
Nat Genet. 1995 Dec;11(4):438-40
pubmed: 7493026
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Nature. 2000 Sep 14;407(6801):227-32
pubmed: 11001065
Circ Res. 2011 Mar 18;108(6):743-50
pubmed: 21415408
Circ Cardiovasc Genet. 2012 Feb 1;5(1):10-7
pubmed: 22144547
Lancet. 2000 Jan 1;355(9197):58-60
pubmed: 10615904
JACC Heart Fail. 2018 May;6(5):364-375
pubmed: 29655825
RNA Biol. 2014;11(9):1122-36
pubmed: 25483043
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
BioDrugs. 2017 Aug;31(4):317-334
pubmed: 28669112
PLoS Genet. 2020 May 26;16(5):e1008639
pubmed: 32453731
Nature. 2010 Jul 1;466(7302):62-7
pubmed: 20596014
Heart. 2012 Jul;98(13):1007-13
pubmed: 22447464
Int J Biol Sci. 2018 Jun 22;14(9):1133-1141
pubmed: 29989099
Gene. 2015 Dec 1;573(2):188-97
pubmed: 26358504
Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):146-154
pubmed: 28687478
Int J Cardiol. 2013 Sep 10;167(6):3075-6
pubmed: 23199551
Biochimie. 1975 Nov-Dec;57(11-12):1249-73
pubmed: 130938
Circ Res. 2014 Mar 28;114(7):1133-43
pubmed: 24526703

Auteurs

Roshini Pradeep (R)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Aqsa Akram (A)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Matthew C Proute (MC)

Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Nageshwar R Kothur (NR)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Petros Georgiou (P)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Tatsiana Serhiyenia (T)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Wangpan Shi (W)

Pathology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Mina E Kerolos (ME)

Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Jihan A Mostafa (JA)

Psychiatry/Cognitive Behavioural Psychotherapy, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Classifications MeSH